Carmen Jeffrey Del - Net Worth and Insider Trading
Carmen Jeffrey Del Net Worth
The estimated net worth of Carmen Jeffrey Del is at least $261,481 dollars as of 2024-09-20. Carmen Jeffrey Del is the Chief Commercial Officer of Catalyst Pharmaceuticals Inc and owns about 12,369 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $261,481. Details can be seen in Carmen Jeffrey Del's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carmen Jeffrey Del has not made any transactions after 2024-08-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Carmen Jeffrey Del
Carmen Jeffrey Del Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carmen Jeffrey Del owns 1 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) .
Click here to see the complete history of Carmen Jeffrey Del’s form 4 insider trades.
Insider Ownership Summary of Carmen Jeffrey Del
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2024-08-09 | Chief Commercial Officer |
Carmen Jeffrey Del Latest Holdings Summary
Carmen Jeffrey Del currently owns a total of 1 stock. Carmen Jeffrey Del owns 12,369 shares of Catalyst Pharmaceuticals Inc (CPRX) as of August 9, 2024, with a value of $261,481.
Latest Holdings of Carmen Jeffrey Del
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2024-08-09 | 12,369 | 21.14 | 261,481 |
Holding Weightings of Carmen Jeffrey Del
Carmen Jeffrey Del Form 4 Trading Tracker
According to the SEC Form 4 filings, Carmen Jeffrey Del has made a total of 5 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Catalyst Pharmaceuticals Inc is the sale of 36,058 shares on August 9, 2024, which brought Carmen Jeffrey Del around $664,188.
Insider Trading History of Carmen Jeffrey Del
- 1
Carmen Jeffrey Del Trading Performance
Carmen Jeffrey Del Ownership Network
Carmen Jeffrey Del Owned Company Details
What does Catalyst Pharmaceuticals Inc do?
Who are the key executives at Catalyst Pharmaceuticals Inc?
Carmen Jeffrey Del is the Chief Commercial Officer of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include VP Development & Management Steve Miller , Chief Medical Officer Gary Ingenito , and Chief Compliance/Legal Officer Brian Elsbernd .
Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary
Over the past 18 months, Carmen Jeffrey Del made 3 insider transaction in Catalyst Pharmaceuticals Inc (CPRX) with a net sale of 83,599. Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 120,000 shares made by David S Tierney , a net sale of 250,000 shares made by Alicia Grande , and a net sale of 230,000 shares made by Gary Ingenito .
In summary, during the past 3 months, insiders sold 301,058 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 301,058 shares. During the past 18 months, 961,406 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 961,406 shares.
Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Pharmaceuticals Inc Insider Transactions
Carmen Jeffrey Del Mailing Address
Above is the net worth, insider trading, and ownership report for Carmen Jeffrey Del. You might contact Carmen Jeffrey Del via mailing address: 355 Alhambra Circle, Suite 801, Coral Gables Fl 33134.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
